The higher local concentration seems to produce faster results based on user reports
Worth noting is that PCACs recommendations are not binding on the FDA, which must still undertake formal rulemaking before any substance is permanently added to the list
Environmental factors like temperature, light, and moisture can compromise the product, leading to degradation of the benzyl alcohol preservative or even promoting microbial growth if conditions are unfavorable
Most practitioners advise against use in anyone with active cancer
Visual Format: Approved vs investigational status map Key Labels: Cosmetic product, compounded peptide, non-injectable route, injectable route, FDA safety concern, approved drug label, regulatory standards, product category Suggested Layout: Use a horizontal status map with four blocks: Cosmetic context, Non-injectable compounding review, Injectable safety concern, and Approved drug labeling. Add a note that product category changes evidence and safety interpretation